Duos
Duos is a healthcare technology company whose platform helps older adults navigate benefits, schedule appointments, and arrange daily services.
Secondary Market Price
How Duos Measures Up
To help you manage your Duos equity, Prospect has run the company through our machine learning model.
Prospect Rating
This rating reflects our belief in this company's potential to grow to that many times its current value in 4 years. For an employee with stock, this rating suggests a potential return on equity, but it also comes with some risk.
Exit Risk
--
Our rating is a reflection of the likelihood of this company achieving a liquidity event for its employees based on the quality of investors, funding stage, founders, and more.
Funding Stage
A company’s funding stage reflects how established it is, how quickly it is scaling, and the average impact an employee may have when joining.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of Duos's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future Duos Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Duos's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
DUOS is a healthcare technology company focused on serving older adults. The company provides a technology-enabled service platform that connects users with health resources, automates benefit navigation, facilitates enrollment in government programs, and schedules appointments on behalf of health plans. The platform also functions as a virtual assistant to help seniors and their families manage daily schedules by arranging rides, food deliveries, and appointments. Founded in 2020, with Karl Ulfers as co-founder and CEO, the company aggregates data from the healthcare ecosystem to simplify access to care and improve health literacy for the aging population.
The company plans to continue advancing its AI-powered care navigation and expand access to benefits and government programs for older adults. DUOS has recently been active in the healthcare industry, with executives participating in events such as the J.P. Morgan Healthcare Conference and AWS re:Invent to discuss AI and technology applications. Recent company updates highlighted the scaling of its AI-powered solution and its role in helping members navigate changes in Medicaid. To support its growth and expansion, DUOS completed a funding round in late 2025, raising $130 million.
- FTV Capital
- Forerunner Ventures
- SJF Ventures
- Castellan Group
- Primetime Partners
- Declaration Partners
- Imaginary Ventures
- Optum Ventures
- Co-Founder, Karl Ulfers
- Co-Founder, Kristen Lynch
- Co-Founder, Anne Marie Aponte
- Co-Founder, Jacques Anderson
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is Duos worth joining?
Evaluating an offer from a startup like Duos requires assessing many factors, particularly the value and structure of the equity package. Tools from platforms like Prospect can help you model the potential future value of your equity compensation to make a more informed decision.
What should I do with my Duos stock?
Managing startup equity involves complex decisions around exercising options and selling shares, all while considering significant tax implications. Platforms like Prospect provide personalized strategies and tools to help you optimize these decisions and maximize your take-home earnings.
Can you sell Duos stock?
As a private company, selling Duos stock is typically possible through secondary markets or company-approved tender offers, though it is less straightforward than selling public stock. Equity management tools from a platform like Prospect can help you navigate these selling opportunities by identifying tax-optimal strategies.
How can I find the value of my Duos stock?
The value of stock in a private company like Duos is primarily determined by its latest 409A valuation and any recent secondary market transactions. You can use platforms like Prospect, which offer predictive models to help forecast the potential future value of your shares based on various scenarios.
What is Duos's equity worth?
The precise worth of a private company's equity is not public information and fluctuates based on factors like new funding rounds and overall business performance. To better understand your personal stake, you can use equity management platforms like Prospect to model different valuation scenarios.
What is Duos's stock ticker symbol?
As a private company, Duos does not have a stock ticker symbol, as these are only assigned when a company lists on a public stock exchange. You can, however, still manage and plan for the future of your pre-IPO shares using specialized equity tools.
Can I buy or sell Duos stock?
Selling private stock like Duos's is sometimes possible via secondary markets, while buying is generally restricted to accredited investors during specific funding events. While not a marketplace, Prospect offers tools to help current stockholders optimize their selling strategy when opportunities arise.
What is the criteria to buy or invest in Duos stock?
Investing in a private startup like Duos is typically limited to accredited investors who meet specific income or net worth thresholds defined by financial regulators. For employees who already hold equity, the focus is generally on managing that asset rather than meeting new investment criteria.
